Asthma Insurance Claim Denied in Massachusetts? Here's Your Full Appeal Guide

Massachusetts is home to world-class medical institutions — but even in the birthplace of academic medicine, asthma patients regularly face insurance denials for biologics, nebulizers, and specialist care. Whether you're insured through MassHealth, a Harvard Pilgrim plan, Blue Cross Blue Shield of MA, or a marketplace plan, Massachusetts law gives you strong rights to fight back.

Why Massachusetts Insurers Deny Asthma Claims

Common denial patterns in Massachusetts:

• Step therapy for biologics: Requiring patients to fail on multiple controller medications before approving Dupixent, Fasenra, Nucala, or Tezspire
• COPD biologic denials: Insurers denying Nucala for COPD despite FDA approval, citing asthma-only formulary criteria
• Harvard Pilgrim prior auth issues: Harvard Pilgrim (now Point32Health with Tufts Health Plan) applies restrictive biologic prior authorization criteria that don't align with FDA labeling
• Prior authorization denials for nebulizers: Home nebulizers denied as duplicative with inhalers
• Out-of-network specialist denials: Western Massachusetts patients often lack in-network pulmonologists and allergists

Massachusetts Insurance Regulator: DOI

The Massachusetts Division of Insurance (DOI) regulates health insurers in Massachusetts.

DOI Consumer Services:

• Phone: 1-617-521-7794
• Toll-free: 1-877-563-4467
• Website: mass.gov/doi
• File a complaint: mass.gov/how-to/file-a-health-insurance-complaint

Massachusetts law provides for External Independent Review: Complete Guide" class="auto-link">external review of adverse benefit determinations. External review decisions from certified IROs are binding on the insurer. Standard reviews are completed within 30 days; expedited reviews within 72 hours.

MassHealth and Asthma Biologics

MassHealth is Massachusetts's Medicaid and CHIP program. MassHealth delivers services through managed care organizations including Fallon Health (NaviCare), Network Health (Tufts Health Together), BMC HealthNet Plan, and Wellsense Health Plan.

MassHealth covers FDA-approved asthma biologics for eligible members with prior authorization. MassHealth's Office of Clinical Affairs sets prior authorization criteria that managed care plans must follow.

For MassHealth denials:

• File an internal appeal with your MassHealth MCO within 30 days of denial
• Request a Board of Hearings: 1-617-847-1200 — MassHealth's fair hearing process
• Contact Greater Boston Legal Services: gbls.org for free legal help
• Contact Massachusetts Legal Assistance Corporation: mlac.org — statewide legal aid directory
• Aid Continuing: MassHealth members can often continue receiving disputed services while a hearing is pending

Harvard Pilgrim and Point32Health: MA Commercial Appeals

Harvard Pilgrim Health Care and Tufts Health Plan merged into Point32Health, one of Massachusetts's largest commercial insurers. Point32Health's prior authorization criteria for asthma biologics have drawn patient complaints. Key appeal strategies for Point32Health denials:

• Request the specific clinical criteria used for the denial — Point32Health is required to provide this
• Compare their internal criteria against FDA prescribing information — if stricter, this is your primary appeal ground
• Request peer-to-peer review between your physician and Point32Health's medical director
• Cite Massachusetts's step therapy reform requirements

COPD Biologic Appeals in Massachusetts

For Massachusetts COPD patients, Nucala (mepolizumab) received FDA approval for COPD with eosinophilic phenotype. If your Massachusetts insurer denies Nucala for COPD:

• Document your COPD diagnosis with spirometry (FEV1/FVC < 0.70 post-bronchodilator), eosinophil count ≥300 cells/μL, and prior exacerbations
• Cite the FDA COPD indication directly in your appeal
• File a DOI complaint if the plan's criteria exclude the FDA-approved COPD indication

Massachusetts also has high rates of occupational lung disease in legacy manufacturing workers, making COPD biologic access particularly important.

FDA-Approved Biologics: Building Your Massachusetts Appeal

• Dupixent (dupilumab): Moderate-to-severe eosinophilic or OCS-dependent asthma; also approved for eczema and nasal polyps
• Fasenra (benralizumab): Severe eosinophilic asthma
• Nucala (mepolizumab): Severe eosinophilic asthma; COPD with eosinophilic phenotype
• Tezspire (tezepelumab): Uncontrolled severe asthma without eosinophil minimum
• Xolair (omalizumab): Moderate-to-severe allergic asthma with IgE sensitization

Include complete eosinophil counts over time, spirometry results, exacerbation and hospitalization records, and full prior medication history with outcome data.

Massachusetts Air Quality and Asthma

Boston's urban neighborhoods — Roxbury, Dorchester, East Boston — face traffic-related air pollution from the Mass Pike, the Southeast Expressway, and Logan Airport flight paths. East Boston's proximity to Logan Airport creates localized air quality problems. Springfield, Worcester, and Holyoke have significant asthma burdens tied to industrial history and housing quality.

Massachusetts's Air Quality Index data from MassDEP (mass.gov/dep) can document local air quality conditions relevant to medical necessity arguments.

Step-by-Step Appeal Process in Massachusetts

1. Get denial in writing: Full EOB and denial letter with specific clinical criteria
2. Internal appeal: File within 30–180 days; include physician letter, lab values, treatment history
3. Peer-to-peer review: Physician contacts Point32Health or Blue Cross medical director
4. Step therapy exception: Formal request with clinical documentation
5. DOI external review: After internal appeal; binding on insurer; 30-day standard timeline
6. DOI complaint: mass.gov/doi — complaint creates regulatory record

Massachusetts Advocacy Resources

• American Lung Association – New England: lung.org | 1-800-586-4872
• Health Care For All: hcfama.org — consumer advocacy and insurance navigation
• Greater Boston Legal Services: gbls.org — free legal help including health benefits
• Massachusetts Advocates for Children: massadvocates.org — pediatric asthma advocacy
• Asthma Regional Council of New England: asthmaregionalcouncil.org — policy and patient education

Fight Back With ClaimBack

Massachusetts patients have access to leading asthma specialists — but only if their insurer doesn't stand in the way. ClaimBack helps you craft appeals that meet Massachusetts DOI's standards and cite the clinical evidence insurers cannot legally dismiss.

Start your appeal at ClaimBack — your care team prescribed this treatment for a reason.

Related Reading:

• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: Which Should You File?
• What Is Medical Necessity?